07:00 , Apr 25, 2011 |  BC Week In Review  |  Company News

AbCelex Technologies Inc., National Research Council of Canada deal

The National Research Council's Institute for Biological Sciences granted diagnostic company AbCelex exclusive, worldwide rights to develop and commercialize the Pentabody platform for all in vivo clinical diagnostic applications. The council will receive an undisclosed...